UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Lindenwold Advisors INC

Lindenwold Advisors INC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,907 shares of the healthcare conglomerate’s stock after acquiring an additional 37 shares during the quarter. UnitedHealth Group makes up approximately 2.6% of Lindenwold Advisors INC’s portfolio, making the stock its 8th largest position. Lindenwold Advisors INC’s holdings in UnitedHealth Group were worth $5,208,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Baron Wealth Management LLC lifted its position in UnitedHealth Group by 32.1% in the third quarter. Baron Wealth Management LLC now owns 1,923 shares of the healthcare conglomerate’s stock valued at $1,124,000 after purchasing an additional 467 shares during the last quarter. Meeder Advisory Services Inc. boosted its position in shares of UnitedHealth Group by 9.5% in the 3rd quarter. Meeder Advisory Services Inc. now owns 16,424 shares of the healthcare conglomerate’s stock worth $9,603,000 after purchasing an additional 1,420 shares in the last quarter. Semus Wealth Partners LLC grew its position in UnitedHealth Group by 4.4% during the 3rd quarter. Semus Wealth Partners LLC now owns 2,302 shares of the healthcare conglomerate’s stock valued at $1,346,000 after purchasing an additional 98 shares during the last quarter. Napa Wealth Management purchased a new position in shares of UnitedHealth Group in the third quarter worth $2,393,000. Finally, Capital City Trust Co. FL lifted its position in UnitedHealth Group by 7.4% during the third quarter. Capital City Trust Co. FL now owns 7,712 shares of the healthcare conglomerate’s stock valued at $4,509,000 after purchasing an additional 534 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Barclays dropped their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $589.65 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market cap of $542.64 billion, a P/E ratio of 38.41, a PEG ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock’s 50-day moving average is $582.75 and its 200 day moving average is $550.66.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the business earned $6.56 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.